Skip to main content
Top
Published in: Breast Cancer Research 2/2007

01-12-2007 | Editorial

Roles for estrogen and progesterone in breast cancer prevention

Author: D Joseph Jerry

Published in: Breast Cancer Research | Issue 2/2007

Login to get access

Abstract

Prevention has long been the holy grail of breast cancer research. The significant reduction in breast cancer risk afforded by a full-term pregnancy early in life suggests the great potential of preventive strategies. In contrast to the risks associated with prolonged exposures, exogenous estrogen and progesterone for short durations can mimic the protective effects of pregnancy in carcinogen-induced mammary tumor models. Rajkumar and coworkers have now demonstrated that these hormones protect mice from mammary tumors initiated by a spectrum of oncogenic alterations that are common in breast cancers. Although differences between rodent models and humans remain, the results reveal that exogenous estrogen and progesterone potently inhibit tumorigenesis through multiple pathways and establish a foundation for strategies to prevent breast cancer.
Literature
1.
go back to reference Rajkumar L, Kittrell FS, Guzman RC, Brown PH, Nandi S, Medina D: Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models. Breast Cancer Res. 2007, 9: R12-10.1186/bcr1645.CrossRefPubMedPubMedCentral Rajkumar L, Kittrell FS, Guzman RC, Brown PH, Nandi S, Medina D: Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models. Breast Cancer Res. 2007, 9: R12-10.1186/bcr1645.CrossRefPubMedPubMedCentral
2.
go back to reference Kumar R, Medina D, Sukumar S: Activation of H-ras oncogenes in preneoplastic mouse mammary tissues. Oncogene. 1990, 5: 1271-1277.PubMed Kumar R, Medina D, Sukumar S: Activation of H-ras oncogenes in preneoplastic mouse mammary tissues. Oncogene. 1990, 5: 1271-1277.PubMed
3.
go back to reference Zarbl H, Sukumar S, Arthur AV, Martin-Zanca D, Barbacid M: Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature. 1985, 315: 382-385. 10.1038/315382a0.CrossRefPubMed Zarbl H, Sukumar S, Arthur AV, Martin-Zanca D, Barbacid M: Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature. 1985, 315: 382-385. 10.1038/315382a0.CrossRefPubMed
4.
go back to reference Yaswen P, Campisi J: Oncogene-induced senescence pathways weave an intricate tapestry. Cell. 2007, 128: 233-234. 10.1016/j.cell.2007.01.005.CrossRefPubMed Yaswen P, Campisi J: Oncogene-induced senescence pathways weave an intricate tapestry. Cell. 2007, 128: 233-234. 10.1016/j.cell.2007.01.005.CrossRefPubMed
5.
go back to reference Becker KA, Lu S, Dickinson ES, Dunphy KA, Mathews L, Schneider SS, Jerry DJ: Estrogen and progesterone regulate radiation-induced p53 activity in mammary epithelium through TGF-beta-dependent pathways. Oncogene. 2005, 24: 6345-6353.PubMed Becker KA, Lu S, Dickinson ES, Dunphy KA, Mathews L, Schneider SS, Jerry DJ: Estrogen and progesterone regulate radiation-induced p53 activity in mammary epithelium through TGF-beta-dependent pathways. Oncogene. 2005, 24: 6345-6353.PubMed
6.
go back to reference Medina D, Kittrell FS: p53 function is required for hormone-mediated protection of mouse mammary tumorigenesis. Cancer Res. 2003, 63: 6140-6143.PubMed Medina D, Kittrell FS: p53 function is required for hormone-mediated protection of mouse mammary tumorigenesis. Cancer Res. 2003, 63: 6140-6143.PubMed
7.
go back to reference Haslam SZ, Woodward TL: Host microenvironment in breast cancer development: epithelial-cell-stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland. Breast Cancer Res. 2003, 5: 208-215. 10.1186/bcr615.CrossRefPubMedPubMedCentral Haslam SZ, Woodward TL: Host microenvironment in breast cancer development: epithelial-cell-stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland. Breast Cancer Res. 2003, 5: 208-215. 10.1186/bcr615.CrossRefPubMedPubMedCentral
8.
go back to reference Schedin P, Mitrenga T, McDaniel S, Kaeck M: Mammary ECM composition and function are altered by reproductive state. Mol Carcinog. 2004, 41: 207-220. 10.1002/mc.20058.CrossRefPubMed Schedin P, Mitrenga T, McDaniel S, Kaeck M: Mammary ECM composition and function are altered by reproductive state. Mol Carcinog. 2004, 41: 207-220. 10.1002/mc.20058.CrossRefPubMed
9.
10.
go back to reference Wang F, Hansen RK, Radisky D, Yoneda T, Barcellos-Hoff MH, Petersen OW, Turley EA, Bissell MJ: Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J Natl Cancer Inst. 2002, 94: 1494-1503.CrossRefPubMedPubMedCentral Wang F, Hansen RK, Radisky D, Yoneda T, Barcellos-Hoff MH, Petersen OW, Turley EA, Bissell MJ: Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J Natl Cancer Inst. 2002, 94: 1494-1503.CrossRefPubMedPubMedCentral
11.
go back to reference Verthelyi D: Sex hormones as immunomodulators in health and disease. Int Immunopharmacol. 2001, 1: 983-993. 10.1016/S1567-5769(01)00044-3.CrossRefPubMed Verthelyi D: Sex hormones as immunomodulators in health and disease. Int Immunopharmacol. 2001, 1: 983-993. 10.1016/S1567-5769(01)00044-3.CrossRefPubMed
12.
go back to reference Rosner B, Colditz GA, Willett WC: Reproductive risk factors in a prospective study of breast cancer: the Nurses' Health Study. Am J Epidemiol. 1994, 139: 819-835.PubMed Rosner B, Colditz GA, Willett WC: Reproductive risk factors in a prospective study of breast cancer: the Nurses' Health Study. Am J Epidemiol. 1994, 139: 819-835.PubMed
13.
go back to reference Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE: Endogenous steroid hormone concentrations and risk of breast cancer among pre-menopausal women. J Natl Cancer Inst. 2006, 98: 1406-1415.CrossRefPubMed Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE: Endogenous steroid hormone concentrations and risk of breast cancer among pre-menopausal women. J Natl Cancer Inst. 2006, 98: 1406-1415.CrossRefPubMed
14.
go back to reference Antoniou AC, Shenton A, Maher ER, Watson E, Woodward E, Lalloo F, Easton DF, Evans DG: Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2006, 8: R72-10.1186/bcr1630.CrossRefPubMedPubMedCentral Antoniou AC, Shenton A, Maher ER, Watson E, Woodward E, Lalloo F, Easton DF, Evans DG: Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2006, 8: R72-10.1186/bcr1630.CrossRefPubMedPubMedCentral
15.
go back to reference Blakely CM, Stoddard AJ, Belka GK, Dugan KD, Notarfrancesco KL, Moody SE, D'Cruz CM, Chodosh LA: Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy. Cancer Res. 2006, 66: 6421-6431. 10.1158/0008-5472.CAN-05-4235.CrossRefPubMed Blakely CM, Stoddard AJ, Belka GK, Dugan KD, Notarfrancesco KL, Moody SE, D'Cruz CM, Chodosh LA: Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy. Cancer Res. 2006, 66: 6421-6431. 10.1158/0008-5472.CAN-05-4235.CrossRefPubMed
Metadata
Title
Roles for estrogen and progesterone in breast cancer prevention
Author
D Joseph Jerry
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 2/2007
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1659

Other articles of this Issue 2/2007

Breast Cancer Research 2/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine